FDA resurrects proposal to gauge quality metrics in pharma manufacturing
The FDA is once again returning to its hotly-contested quality metrics program for pharma manufacturers, even as companies have expressed major reservations.
The agency’s focus …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
